D. Sezen Et Al. , "Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease," SEMINARS IN RADIATION ONCOLOGY , vol.31, no.3, pp.217-226, 2021
Sezen, D. Et Al. 2021. Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease. SEMINARS IN RADIATION ONCOLOGY , vol.31, no.3 , 217-226.
Sezen, D., Verma, V., He, K., Abana, C. O., Barsoumian, H., Ning, M. S., ... Tang, C.(2021). Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease. SEMINARS IN RADIATION ONCOLOGY , vol.31, no.3, 217-226.
Sezen, Duygu Et Al. "Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease," SEMINARS IN RADIATION ONCOLOGY , vol.31, no.3, 217-226, 2021
Sezen, Duygu Et Al. "Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease." SEMINARS IN RADIATION ONCOLOGY , vol.31, no.3, pp.217-226, 2021
Sezen, D. Et Al. (2021) . "Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease." SEMINARS IN RADIATION ONCOLOGY , vol.31, no.3, pp.217-226.
@article{article, author={Duygu Sezen Et Al. }, title={Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease}, journal={SEMINARS IN RADIATION ONCOLOGY}, year=2021, pages={217-226} }